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ABSTRACT
Extracellular vesicles (EVs) are biological vectors that can modulate the metabolism of target cells
by conveying signalling proteins and genomic material. The level of EVs in plasma is significantly
increased in cardiometabolic diseases associated with obesity, suggesting their possible partici-
pation in the development of metabolic dysfunction. With regard to the poor definition of
adipocyte-derived EVs, the purpose of this study was to characterise both qualitatively and
quantitatively EVs subpopulations secreted by fat cells. Adipocyte-derived EVs were isolated by
differential centrifugation of conditioned media collected from 3T3-L1 adipocytes cultured for
24 h in serum-free conditions. Based on morphological and biochemical properties, as well as
quantification of secreted EVs, we distinguished two subpopulations of adipocyte-derived EVs,
namely small extracellular vesicles (sEVs) and large extracellular vesicles (lEVs). Proteomic analyses
revealed that lEVs and sEVs exhibit specific protein signatures, allowing us not only to define
novel markers of each population, but also to predict their biological functions. Despite similar
phospholipid patterns, the comparative lipidomic analysis performed on these EV subclasses
revealed a specific cholesterol enrichment of the sEV population, whereas lEVs were characterised
by high amounts of externalised phosphatidylserine. Enhanced secretion of lEVs and sEVs is
achievable following exposure to different biological stimuli related to the chronic low-grade
inflammation state associated with obesity. Finally, we demonstrate the ability of primary murine
adipocytes to secrete sEVs and lEVs, which display physical and biological characteristics similar
to those described for 3T3-L1. Our study provides additional information and elements to define
EV subtypes based on the characterisation of adipocyte-derived EV populations. It also under-
scores the need to distinguish EV subpopulations, through a combination of multiple approaches
and markers, since their specific composition may cause distinct metabolic responses in recipient
cells and tissues.
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Introduction
Obesity has reached epidemic proportions and constitu-
tes a major cause of co-morbidities including type 2
diabetes, cardiovascular diseases and various cancers.
Because of its adipocyte lipid storage capacities, white
adipose tissue (WAT) constitutes the main energy supply
in the body, being mobilised according to the body’s
needs and therefore implying a state of permanent com-
munication with other organs in the body. However,
adipocytes are not restricted to a fat-storage capacity,
but can secrete many adipokines that mediate cell
signalling in an autocrine or a paracrine manner.
Secretion of these different signalling mediators is often
dysregulated with obesity and contributes to a low-grade
inflammatory state associated with obesity; as a conse-
quence, they directly underpin the development of cardi-
ometabolic complications [1].
Recent studies have highlighted extracellular vesicles
(EVs), cell-derived membranous vesicles secreted in the
extracellular environment, as relevant carriers of biolo-
gical messages. Plasmatic EV levels [2–4] and EV mar-
kers [5] have been found to be significantly higher in
obese patients. Moreover, WAT-derived EVs show
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immunomodulatory properties in that they are able to
convert macrophages towards a pro-inflammatory phe-
notype in vitro [6] and to modulate insulin signalling
in muscle and liver cells [7]. Systemic injection of EVs
from obese WAT explants into lean mice mediates the
activation of macrophage-induced insulin resistance,
highlighting their potential pathophysiological roles
[8]. Many studies have confirmed the ability of differ-
ent adipocyte models to secrete EVs, including rat
isolated adipocytes [9,10], 3T3-L1 cell adipocytes [11]
and a human preadipocyte differentiated cell model
[6]. In addition, specific cellular stimuli enhance the
secretion of adipokines, including adiponectin [12] and
aP2/FABP4 [13,14], through their association with
EVs. Moreover, adiponectin was detected in plasmatic
EV samples [15], suggesting that adipocyte-derived
EVs may be active vectors of communication in vivo.
Two types of EV can be generally distinguished [16].
Microvesicles are shed from the plasma membrane as a
consequence of cytoskeleton reorganisation combined
with negatively charged phosphatidylserine (PS) expo-
sure in the outer membrane [17,18]. Exosomes are endo-
some-derived vesicles formed in multivesicular bodies
(MVBs) and released after the fusion of these with the
plasmamembrane [16]. Besides their distinct intracellular
origin, microvesicles and exosomes also represent two EV
subtypes with different size ranges: microvesicles (50 nm/
100 nm to 1 µm) are described as being bigger than
exosomes (30–100 nm). However, the terminology “exo-
somes” has been widely used for small EVs, regardless of
their endolysosomal cellular origin, therefore denoting a
mix of EVs from different intracellular origins and with
distinct functional properties. Moreover, specific subsets
of proteins, long considered to be exosomal markers,
appear to be EV-enriched proteins since they may also
be retrieved in other EV subtypes [19]. Considering the
biological complexity of EVs, which is further influenced
by the cellular context, no standardised analysis proce-
dure has yet been validated to allow a clear separation of
microvesicles from exosomes. Therefore, a combination
of technical approaches appears to be essential to provide
clues about the biological composition and functions of
EV populations [20].
Despite the demonstrated ability of fat cells to
secrete a considerable amount of EVs [21], adipocyte
EV subtypes and their compositions have been poorly
defined. The aim of this study was to quantitatively and
qualitatively define fat cell-derived EV subpopulations
through a combination of microscopic, biochemical
and high-resolution mass-spectrometry (MS) technol-
ogies. By isolating adipocyte-derived EV subtypes
through differential centrifugation steps, we demon-
strated the secretion of two distinct populations,
termed small extracellular vesicles (sEVs) and large
extracellular vesicles (lEVs). Based on our results, we
show that these two EV subtypes can be distinguished
based on specific protein and lipid signatures, and
differential responses to stimuli. This work provides
evidence that the different EV subtypes secreted by
3T3-L1 mature adipocytes display distinct biological
and biochemical properties, and could predict different
metabolic responses in recipient cells and/or tissues.
Methods
Reagents
All reagents, unless otherwise specified, were obtained
from Sigma Aldrich (Saint-Quentin Fallavier, France).
Oleic acid (OA) and palmitic acid (PA)were conjugated
to bovine serum albumin (BSA) as previously described,
before their incubation in cell media [22]. Tumour necro-
sis factor-α (TNFα) was obtained from Miltenyi Biotec
(Paris, France) and interferon-γ (INFγ) Immunotools
(Friesoythe, Germany).
Cell culture
3T3-L1 cells were maintained in high-glucose Dulbecco’s
modified Eagle’s medium (DMEM) with 10% donor calf
serum at 37°C and 10% carbon dioxide (CO2) as pre-
viously described [23]. In brief, 3T3-L1 cells were induced
to differentiate 2 days post-confluence in DMEM 10%
foetal bovine serum (FBS) by adding 250 µM 3-isobutyl-
1-methylxanthine (IBMX), 1.25 µM dexamethasone
(Dex) and 250 nM insulin for 3 days, and then cultured
with 100 nM insulin alone until complete adipocyte dif-
ferentiation (days 6–8). EVs were isolated from 24 h
serum-free conditioned media of mature 3T3-L1 adipo-
cytes (days 6–8 of differentiation) from at least four 15 cm
diameter plates. Treatment of overnight serum-deprived
mature adipocytes was performed for 24 h before EV
isolation with the following agents: BSA-conjugated OA
and PA (500 µM), 8-bromoadenosine 3’,5’-cyclic mono-
phosphate (8-Br-cAMP) (1 µM), ionomycin (1.5 µM),
angiotensin II (10 nM), TNFα (10 ng/mL) and INF
(100U/mL corresponding to 5ng/mL).
Isolation of primary adipocytes from murine
adipose tissues
Adipocytes were isolated by collagenase digestion of
3–4 g of visceral fat pads from 4–6-month-old mice by
the method of Rodbell [24] and cultured in endothe-
lial cell growth medium supplemented with 4-(2-
hydroxyethyl)-1-piperazineethanesulphonic acid
2 M. DURCIN ET AL.
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(HEPES) (10 mM) and albumin fatty acid free (0.1%),
pH 7.4. EV subpopulations were isolated from 24 h
serum-free conditioned media. The number of iso-
lated adipocytes present in the fat-digested tissue
was estimated by indirect calculation based on the
mean cell volumes of fat cells (following measure-
ments of fat cell diameters on microscopic images of
isolated adipocyte suspensions), the lipid content of
the dissected fat pads and lipid density (0.915) accord-
ing to a well-described protocol [25].
Production and isolation of EVs
Serum-free conditioned media were collected to isolate
total EVs, lEVs and sEVs. The conditioned medium was
first spun at 1500 × g for 20 min to remove cells and cell
debris. Total EVs were pelleted by direct ultracentrifuga-
tion of the cell-cleared conditioned medium at
100,000 × g for 1 h at 4°C (rotor MLA-50, Beckman
Coulter Optima MAX-XP Ultracentrifuge). After two
washing steps in NaCl 0.9% (rotor TLA 100.4, Beckman
Optima TLXUltracentrifuge), total EV pellets were resus-
pended in NaCl. lEVs were recovered from cell-cleared
supernatants following centrifugation at 13,000 × g for
60 min, followed by two washing steps in NaCl, and
resuspended in sterile NaCl. sEVs were further isolated
from lEV-depleted supernatants following a 100,000 × g
ultracentrifugation step for 1 h at 4°C (rotor MLA-50,
Beckman Coulter Optima MAX-XP Ultracentrifuge) and
two washes in NaCl (see Figure 1(A)). The protein
amount in the EV preparations was estimated by a DC
protein assay (BioRad, Marnes la Coquette, France) using
BSA as a standard.
Separation of EVs on sucrose gradients
First, 500 µL of lEVs or sEVs (corresponding to a total
protein content of 120 µg) was loaded on top of a
sucrose density gradient in an SW40 tube. The density
gradient was prepared by layering successive sucrose
solutions (31 fractions of 350 µL) of decreasing density
(2.0 M to 0.4 M) on top of 700 µL 2.5 M sucrose, as
previously described [26]. After ultracentrifugation at
200,000 × g for 18 h at 4°C, 12 fractions of 1 mL were
collected. Fraction 1 (1 mL from the top of the gradi-
ent) was not further analysed, since proteins sticking to
the tube wall were recovered in this fraction in an
unspecific manner (data not shown). Sucrose density
was measured on an aliquot of each fraction using a
refractometer. Five millilitres of phosphate-buffered
saline (PBS) was added to each 1 mL fraction collected,
before recentrifugation at 100,000 × g for 70 min at 4°
C. Pellets (visible or not) were resuspended in 50 µL
PBS, and divided into two aliquots of 25 µL before
storage at −80°C and their further analysis by sodium
dodecyl sulphate–polyacrylamide gel electrophoresis
(SDS-PAGE).
Cell lysates, SDS-PAGE and immunoblotting
Adipocytes were resuspended in lysis buffer [50 mM Tris
pH 7.4, 0.27 M sucrose, 1 mM Na-orthovanadate pH 10,
1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM
ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraa-
cetic acid (EGTA), 10mMNa β-glycerophosphate, 50mM
NaF, 5 mM Na pyrophosphate, 1% (w/v) Triton X-100,
0.1% (v/v) 2-mercaptoethanol and cOmplete™ Protease
Inhibitor Cocktail, (Roche Diagnostics, Meylan, France)].
Whole cell lysates were centrifuged at 15,000 × g for 10min
at 4°C and stored at −80°C.
Cell lysates (8 µg), EV preparations (8 µg) and sucrose
gradient-isolated fractions were diluted with Laemmli
Buffer 6X (in reducing conditions, except for tetraspanin
detection, where DTT was excluded), subjected to SDS-
PAGE on 4–12% bis-acrylamide resolving gels (Novex®
NuPAGE® precast gels; Life Technologies, Saint Aubin,
France) and transferred on to nitrocellulose membranes
(GEHealthcare, Pittsburgh, PA,USA). Themembranewas
blocked for 90 min at room temperature in 5% (w/v) BSA/
Tris-buffered saline (TBS) (50 mM Tris-HCl pH 7.6,
150 mM NaCl) supplemented with 0.1% (v/v) Tween-20.
Antibodies for Western blot were: adiponectin (PA1-054;
Thermo Scientific, Villebon sur Yvette, France), actinin-4
(GTX15648; Genetex, Hsinchu, Taiwan), Alix (#611620;
BD Biosciences, Le Pont de Claix, France), annexin A2
(#610068; BD Biosciences), aP2/FABP4 (#2120; Cell
Signaling, ZA Leiden, The Netherlands), β-actin (#4970,
clone 13E5; Cell Signaling), caveolin-1 (#SC-894, N20;
Santa Cruz Biotechnology, Heidelberg, Germany), CD9
(#553758; BD Biosciences), CD63 (#D263-3, MBL
International, Woburn, Massachusets, USA), CD81 (#sc-
18877; Santa Cruz Biotechnology), endoplasmin (#ADI-
SPA-850; Enzo Life Sciences, Villeurbane, France), fatty
acid synthase (FAS) (a gift from Isabelle Dugail, INSERM,
Paris, France), flotillin-2 (#610383; BDBiosciences),Mfge8
(#D199-3; MBL), major vault protein (MVP) (#ab2376;
Abcam, Paris, France), Syntenin-1 (gift from Pascale
Zimmerman, Centre de Recherche en Cancérologie de
Marseille; or #ab19903, Abcam), TSG101 (GTX70255;
Genetex), 14-3-3 (#8312; Cell Signaling, detect all iso-
forms). Nitrocellulose membranes were washed three
times in TBS 0.1%Tween-20 (v/v) for 5min before incuba-
tion with horseradish peroxidase (HRP)-coupled second-
ary antibodies (Jackson Immuno-Research, West Grove,
Pennsylvania, USA). Protein signals were visualised using
enhanced chemiluminescence (Immunocruz, Santa Cruz
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Figure 1. 3T3-L1 adipocytes secrete distinct extracellular vesicle (EV) subpopulations: large extracellular vesicles (lEVs) and small extracellular
vesicles (sEVs). (A) Schematic representation of the successive differential centrifugation steps used to isolate the EV subpopulations released
bymature 3T3-L1 adipocytes. Total EVs and EV subtypes, namely lEVs and sEVs, were isolated from 24 h serum-deprived 3T3-L1 culturemedia
(CM) after the removal of cells and cell debris. (B) EV production based onprotein content of EV subtypes. The protein content of each EV pellet
normalised to the protein content of the original productive 3T3-L1 adipocytes is presented. n= 3–9 independent EV preparations, **p< 0.01
(Mann–Whitney rank test). (C,D) Transmission electron microscopy images of lEV (C) and sEV (D) pellets. Note that scale bars differ between
images (left images, scale bars = 200 nm; right images, scale bars = 100 nm). (E–H) Nanoparticle tracking analysis of lEV and sEV populations.
Determination of size distribution and concentration of lEV (E) and sEV (F) preparations. Indicated concentrations refer to the initial
concentration of EVs in the conditioned media from which they were isolated and are expressed as 104 particles/mL. Each coloured line
represents the mean of five videos acquired for a single biological sample. EV mean size (G) and EVs released per cell (H) are presented. The
same colours as in (E) and (F) are used to distinguish the four different lEV/sEV preparations analysed. lEV pellets contained vesicles of larger
size than sEV pellets. 3T3-L1 adipocytes secrete substantially more sEVs than lEVs in serum-deprived conditions. n = 4 biological samples for
lEVs and for sEVs, *p < 0.05 (Mann–Whitney rank test).
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Biotechnology) with a Chemi-smart 5000 imager system
(Vilber-Lourmat, Marne La Vallée, France).
Nanoparticle tracking analysis
EV samples were diluted in sterile NaCl 0.9% before nano-
particle tracking analysis (NTA). NTA was undertaken
using the NanoSight NS300 (Malvern Instruments,
Malvern, UK) equipped with a 405 nm laser. Ninety-sec-
ond videos were recorded in five replicates per sample with
optimised set parameters (the detection threshold was set
to 7 and 5, respectively, for lEVs and sEVs). Temperature
was automatically monitored and ranged from 20°C to 21°
C. Videos were analysed when a sufficient number of valid
trajectories was measured. Data capture and further ana-
lysis were performed using the NTA software version 3.1.
At least three independent biological samples of each EV
subtype were analysed, and the presented results corre-
spond to the mean of the five videos taken for a given
biological sample.
Electron microscopy
EV preparations were first fixed for 16 h at 4°C with 2.5%
glutaraldehyde (LFGDistribution, Lyon, France) in 0.1M
Sorensen buffer pH 7.4. lEV and sEV fractions were then
deposited on Formvar®-coated copper grids and nega-
tively stained with phosphotungstic acid 1% (w/v) for
30 s. Grids were rinsed briefly with milliQ water and left
to air dry. Grids were then observed with a Jeol JEM 1400
microscope (Jeol, Croissy sur Seine, France) operated at
120 keV.
Proteomic analysis of EV content by MS
Protein in-gel digestion
After silver staining following the method of Shevchenko
et al. [27], protein bands were excised from one-dimen-
sional SDS-PAGE. Each lane of short migration was cut
and washed for 15 min with an acetonitrile/100 mM
ammonium bicarbonate mixture (1:1). Digestion was per-
formed in 50 mM ammonium bicarbonate pH 8.0 and the
quantity of modified trypsin (Promega, sequencing grade)
was 0.1 μg per sample. Digestion was achieved for 6 h at
37°C. The supernatant was conserved. Peptides were
extracted by 5% formic acid in water/acetonitrile (v/v).
Supernatant and extracted tryptic peptides were dried
and resuspended in 50 µL of 0.1% (v/v) formic acid and
2% (v/v) acetonitrile.
Nano-liquid chromatography–tandem mass
spectrometry: proteomic analysis
A Q Exactive (Thermo Fisher Scientific) coupled to an
Eksigent 2D nano LC (AB-Sciex, MA, USA) was used
for the nano-liquid chromatography–tandem mass
spectrometry (LC-MS/MS) analysis. Four microlitres
of sample was injected on the nano LC-Ultra system
chain. The sample was loaded at 7.5 µL/min on the
precolumn cartridge (C18, 5 µm, 120 Å, 20 mm
Nanoseparations) and desalted with 0.1% formic acid.
Then, peptides were separated with a gradient of acet-
onitrile on the reverse-phase column C18 (stationary
phase: C18 Biosphere, 3 µm; column: 75 µm i.d.,
150 mm; Nanoseparations). Buffers were 0.1% formic
acid in water (A) and 0.1% formic acid in acetonitrile
(B). The peptide separation was achieved with a linear
gradient from 5% to 35% B for 40 min at 300 nL/min−1
(total gradient of 50 min). Eluted peptides were ana-
lysed online using a nanoelectrospray interface.
Ionisation (1.8 kV ionisation potential) was performed
with stainless steel emitters (30 µm i.d.; Thermo
Electron). Capillary temperature was 250°C. Peptide
ions were analysed using Xcalibur 3.0.63 (Tune version
2.3.0.1765) with the following data-dependent acquisi-
tion steps: (i) full MS scan [mass-to-charge ratio (m/z)
400 to 1400]; and (ii) MS/MS. Step 2 was repeated for
the eight major ions detected in step 1. Dynamic exclu-
sion was set to 40 s. The lock mass option “best” was
chosen, MS resolution was 70,000 at m/z 400, auto gain
control was 3e6 and maximum injection time was
250 ms. For MS2, the resolution was 17,500 at m/z
400, auto gain control was 5e4 with a maximum injec-
tion time of 120 ms, the isolation window was m/z = 3,
the normalised collision energy was 27, the underfill
ratio was 3%, the intensity threshold was 1.3e4 and the
charge state was 2, 3.
Data processing and bioinformatics analysis
The Mus musculus database was downloaded from the
UniProt KB database site (www.uniprot.org, January
2015, 24,721 protein entries). This database was
merged and, in conjunction with reverse and contami-
nant databases, searched by X!Tandem (Sledge
Hammer version 2013.09.01.1, http://www.thegpm.
org/tandem/) using X!TandemPipeline (version 3.3.3)
developed by the PAPPSO platform (http://pappso.
inra.fr/bioinfo/). Enzymatic cleavage was declared as a
trypsin digestion with one possible miscleavage. Cys
carboxyamidomethylation and Met oxidation were set
to static and possible modifications, respectively. The
precursor mass was 10 ppm and the fragment mass
tolerance was 0.02 Da. A refinement search was added
JOURNAL OF EXTRACELLULAR VESICLES 5
D
ow
nl
oa
de
d 
by
 [1
93
.52
.40
.1]
 at
 08
:54
 02
 N
ov
em
be
r 2
01
7 
with similar parameters except for semi-trypsic peptide
and possible N-ter proteins. For proteomic data, only
peptides with an E value smaller than 0.1 were
reported. Identified proteins were filtered and grouped
using X!TandemPipeline (http://pappso.inra.fr/bioinfo/
xtandempipeline/) according to the following require-
ments: (i) a minimum of two different peptides with an
E value smaller than 0.0; and (ii) a protein log (E value,
calculated as the product of unique peptide E values)
smaller than 2.10–3. These criteria led to a peptide false
discovery rate (FDR) of 0.27% when all conditions
were combined. To take redundancy into account,
proteins with at least one peptide in common were
grouped. This allowed the grouping of proteins with
similar functions. Within each group, proteins with at
least one specific peptide relative to other members of
the group were reported as subgroups. Only proteins
detected on at least two biological replicates, based on
their identification by at least two distinct peptides,
were taken into account for qualitative analysis.
Label-free quantification of proteins was achieved
using two different quantification methods: peptide
quantification by spectral counting (SC) [28] and
extracted ion chromatography (XIC) analysis [29].
The first method, SC, is based on the number of mass
spectra (obtained with tryptic peptides in MS) assigned
to one protein and is correlated with protein abun-
dance. This quantification is based on the fact that
the more of a particular protein is present in a sample,
the more MS spectra are detected for peptides of that
protein. This approach allows detection of the absence
or presence of a given protein, but tends to overesti-
mate the amount of low-abundance proteins because of
the shared peptides with high-abundance proteins,
resulting in low resolution to detect small abundance
changes. In this analysis, a difference of five spectra
between each EV subpopulation for a protein was set as
the filter. The second method, XIC analysis, involves
the quantification of the ion precursor (surface area) of
a given peptide, the intensity of which is correlated
with the protein abundance. The XIC-based approach
has higher accuracy, sensitivity and specificity as it can
detect low peptide quantities in a sample, but it cannot
support qualitative variations in a given protein (pre-
sence/absence). MassChroQ software [30] was used for
the XIC approach. All the previously identified pep-
tides were selected for quantification. XIC extraction
was performed using a peak detection threshold
between 30,000 and 50,000 and a range of 10 ppm.
XIC analyses were performed on log10-transformed
data. Peptides showing a standard deviation of reten-
tion time higher than 40 s were removed. Peptides were
quantified based on XIC using MassChroqR_0.2.0.
Experimental design and statistical rationale
Concerning the samples used for MS experiments, four
independent biological replicates were generated for
each of the three EV subpopulations studied (EVs,
lEVs and sEVs). Using four replicates gave the best
compromise to duly handle experimental variability
and to perform quantitative analysis. All statistical pro-
cedures were carried out under the R v3.1.1 environ-
ment [31] using base packages developed by the
PAPPSO platform (http://pappso.inra.fr/index.php?).
Only peptides present in less than 2% of the sample
and belonging to multiple proteins were removed.
Changes in protein abundance were detected by analy-
sis of variance. For both methods (XIC and SC), pro-
teins were considered significant when the adjusted p
value was < 0.05.
Lipidomic analysis by MS
EV lipid content was extracted with the methyl-tert-
butyl ether (MTBE) method according to Matyash
et al. [32]. Lipid extracts were resuspended in 500 µL
CHCl3/MeOH 1:1, and 12:0/13:0 phosphatidylethano-
lamine (PE), 17:0/20:4 PE, 14:1/17:0 PE, 12:0/13:0
phosphatidylcholine (PC), 17:0/20:4 PC, 14:1/17:0 PC,
17:0 lysophosphatidylcholine (LPC), TG-Mix LM6000,
sphingolipid (SP)-Mix LM6002 (2 µM each) 12:0/13:0
PS, 17:0/20:4 PS, 14:1/17:0 PS, diacylglycerol (DG)-Mix
LM6001 (3 µM each), 12:0/13:0 phosphatidylinositol
(PI), 17:0/20:4 PI and 14:1/17:0 PI (3.5 µM each)
were added as internal standards. Two microlitres was
injected on a Thermo Hypersil GOLD C18,
100 × 1 mm, 1.9 µm high-performance liquid chroma-
tography (HPLC) column, used with an Accela HPLC
(Thermo Scientific). Solvent A was water with 1%
ammonium acetate and 0.1% formic acid, and solvent
B was acetonitrile/2-propanol 5:2 with 1% ammonium
acetate and 0.1% formic acid. The gradient ran from
35% to 70% solvent B in 4 min, then to 100% solvent B
in another 16 min, where it was held for 10 min. The
flow rate was 250 µL/min.
Data acquisition was basically performed according
to Fauland et al. [33] by an Orbitrap-MS (LTQ-
Orbitrap, Thermo Scientific) full scan in preview
mode at a resolution of 100 k and < 2 ppm mass
accuracy with external calibration. The spray voltage
was set to 5000 V, capillary voltage 35 V and the tube
lens 120 V. Capillary temperature was 250°C. From the
FT-MS preview scan, the 10 most abundant m/z values
were picked in data-dependent acquisition mode, frag-
mented in the linear ion trap analyser and ejected at
nominal mass resolution. Normalised collision energy
was set to 35%, the repeat count was 2 and the
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exclusion duration was 1 min. Data were further ana-
lysed using Lipid Data Analyzer, a custom-developed
software tool described in more detail by Hartler
et al. [34].
Cholesterol measurement
Cholesterol content was measured on isoproterenol-
resuspended EV preparations using a commercial kit
(Thermo Scientific). The absorbance of the cholesterol-
based reaction was measured at 510 nm, and choles-
terol concentration was calculated based on a choles-
terol standard curve also made using isoproterenol.
Annexin V binding analysis
Annexin V binding properties to both adipocyte-derived
lEVs and sEVs were measured by flow cytometry using the
kit Annexin V-FITC (Miltenyi Biotec). Five microlitres of
lEVs (corresponding to 0.5 µg of lEV content) werewashed
with annexin V 1X binding buffer, centrifuged at
13,000 × g for 15 min, then incubated with 5 µL of annexin
V-FITC in annexin V 1X buffer in the dark for 45 min.
Following staining, lEVs were washed twice in annexin V
1X buffer, pelleted and resuspended in 200 µL of annexin
V 1X buffer for flow cytometry analysis. Given the small
size of exosomes, 5 µg of sEVs was combined with 10 µL
latex beads (Molecular Probes A37304) as described pre-
viously [35]. sEV-coated beads were labelled with annexin
V-FITC (or annexin V 1X buffer as a background control)
for 45 min in the dark, and washed with annexin V 1X
buffer. Annexin V positivity was determined on a
MACSQuant flow cytometer. Data were further analysed
using MACSQuant analysis software.
Statistical analysis
Statistical analysis of the results was performed using
non-parametric tests such as the Mann–Whitney or
Wilcoxon signed-rank test, respectively, for comparison
of non-paired or paired samples. The differences were
considered significant for p values < 0.05 and stated as
follows: * for p < 0.05, **p < 0.01 and ***p < 0.001.
Results
3T3-L1 adipocytes secrete two EV size populations:
lEVs and sEVs
EVs were isolated from 24 h serum-free conditioned
media of 3T3-L1 mature adipocytes using ultracentri-
fugation-based isolation (Figure 1(A)). Considering the
limited contribution of apoptosis to adipose tissue
development and the fact that 3T3-L1 preadipocytes
acquire a relative resistance to apoptosis as they differ-
entiate, we did not investigate the secretion of apopto-
tic bodies from adipocytes.
Absolute quantification, based on EV protein content,
reveals that the sEV population was predominant over
lEVs (Figure 1(B)). Transmission electron microscope
(TEM) imaging of EV preparations allowed further visua-
lisation of the morphological characteristics of these two
EV subpopulations. The lEV fraction included a hetero-
geneous population of vesicles, with a well-delimited dou-
ble membrane, differing greatly in size, shape and electron
density (Figure 1(C). Conversely, the sEV fraction corre-
sponded to a pool of smaller spherical vesicles of similar
sizes, with cup-shaped morphology (Figure 1(D). Size dis-
tribution analysis of both EV subtypes, based on diameter
measurements of both EV subpopulations on TEM
images, indeed showed distinct size patterns for lEVs and
sEVs (Figure S1). NTA confirmed different size distribu-
tions between the two EV preparations, with a higher
dispersion in large vesicles for lEV preparations (Figure 1
(E)), whereas sEVs peaked between 80 and 120 nm
(Figure 1(F)). Therefore, these two subpopulations of
EVs differ greatly in size, as illustrated by a mean size
ranging between 100 and 200 nm for lEVs, and close to
or below 100 nm for sEVs (Figure 1(G)). Furthermore, lEV
concentrations were several hundred times lower than sEV
concentrations, confirming the ability of 3T3-L1 adipo-
cytes to secrete sEVs in large proportions (Figure 1(E,F)).
Once normalised per emitting cell, a mature 3T3-L1 adi-
pocyte will secrete an average of 11 ± 5 lEVs and 843 ± 185
sEVs (Figure 1(H)).
Adipocyte-derived lEVs and sEVs both express
classical EV markers but display different flotation
behaviours on sucrose gradients
A few proteins are widely used to characterise exo-
somes, and more largely mixed EV populations,
including Alix, tetraspanins and lipid-raft associated
proteins such as caveolins and flotillins [20,36]. We
thus compared the association of these EV markers by
analysing on Western blots the same amount of pro-
teins from each EV isolated pellet (total EVs, lEVs and
sEVs) or from the secreting adipocyte cell lysates
(Figure 2(A)). As expected, total EVs secreted by
3T3-L1 adipocytes harbour tetraspanins (CD9,
CD63, CD81), Alix and Mfge8, as well as caveolin-1
and flotillin-2 (Figure 2(A)). Separation between lEV
and sEV subpopulations revealed that the membra-
nous lipid-raft proteins caveolin-1 and flotillin-2 were
preferentially associated with the lEV fraction
(Figure 2(A,B)). The same was true for Mfge8,
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Figure 2. Adipocyte-derived large extracellular vesicles (lEVs) and small extracellular vesicles (sEVs) differentially carry classical extracellular
vesicle (EV) markers and display different flotation behaviours on sucrose gradients. (A) Western blot analysis of different EV markers in EV
subpopulations isolated from adipocytes. The different centrifugation pellets, including either total EVs or lEVs and sEVs, were resuspended
in NaCl and quantified for their protein content. lEVs (13,000 × g pellet) and sEVs (100,000 × g pellet) were collected from the same batch of
cells cultured in the same conditions (see Methods). Eight micrograms of total adipocyte-derived EVs (EVs), lEVs or sEVs was loaded on a
sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) gel, together with 8 µg of original adipocyte cell lysate (CL), and
analysed by immunoblotting for the presence of the following proteins: Alix, Mfge8, the tetraspanins CD63, CD81 and CD9, TSG101, flotillin-
2, β-actin and caveolin-1. Ten micrograms of EVs and CL were specifically loaded to allow detection of β-actin in the total EV sample. One
representative blot for each protein is presented. (B) Quantification of the distribution of the different EV markers between lEVs and sEVs,
analysed by Western blot. At least three independent preparations of lEVs and sEVs were analysed for the presence of the EV markers by
Western blot, following equal protein loading (8 µg). For each protein analysed, the signal intensity (SI) of the protein signal band was
calculated using ImageJ software, as follows: AUlEVs = (SIlEVs)/(SIlEVs + SIsEVs) and AUsEVs = (SIsEVs)/(SIlEVs + SIsEVs). Each colour represents an
independent experiment, with lEV and sEV preparations derived from the same secreting cells. *p < 0.05 (paired Student’s t test), **p < 0.01,
****p < 0.0001. (C,D) Separation of lEV (C) and sEV (D) preparations on sucrose gradients. Equivalent protein amounts of lEVs and sEVs
(120 µg) resuspended in 500 µL NaCl were loaded on to a sucrose gradient (2.0 M to 0.4 M). Collected sucrose fractions were recentrifuged,
resuspended in phosphate-buffered saline and divided into two portions, to be loaded on SDS-PAGE in either reducing or non-reducing
conditions, the latter gel being used for tetraspanin detection. The density of the collected sucrose fractions was determined by a
refractometer and is indicated above the gel. lEV- and sEV-derived sucrose density fractions were probed with the following EVmarkers: Alix,
Mfge8, CD63, CD9 and β-actin. lEV pellets were found to float mainly at densities between 1.20 and 1.22 g/mL, according to Mfge8, caveolin-
1, flotillin-2 and CD63 signals (C). Alix was undetectable in this lEV-separated sucrose gradient. By contrast, sEV pellets were recovered at
lower densities, between 1.14 and 1.20 g/mL, as illustrated by Alix, Mfge8, CD63 and CD9 signals (D).
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consistent with the relative abundance of this periph-
eral membrane protein in lEVs [19]. β-Actin was
exclusively recovered in the lEV fraction, and unde-
tectable in the sEV fraction (data not shown), in
agreement with the critical role of cytoskeleton remo-
delling in the process of microvesicle shedding [37].
By contrast, sEVs were significantly enriched with
Alix, the endosomal sorting complexes required for
transport I (ESCRT-I) component TSG101 and the
tetraspanins CD9, CD63 and CD81 (Figure 2(A,B)).
Since differential ultracentrifugation protocols allow
recovery of a crude pellet of the EV population, a classic
way to improve the separation of membrane-enclosed
vesicles is to allow the EV pellet to float into an over-
lying sucrose gradient. The distribution of EV markers is
then studied in the collected fractions following lEV and
sEV sucrose density gradient separation. By this means,
we observed that lEVs were mainly recovered in density
fractions between 1.20 and 1.22 g/mL, according to
caveolin-1 and flotillin-2 signals (Figure 2(C)). The
sEVs floated at lighter densities, between 1.14 and
1.20 g/mL, as illustrated by CD9, CD63 and Alix detec-
tion (Figure 2(D), in agreement with densities and mar-
kers generally described in the literature [16]. Mfge8
presented a large pattern of expression over the lEV
and sEV-derived fractions (Figure 2(C,D)). By contrast,
Alix was undetectable in lEV-derived sucrose fractions
(data not shown) and CD63 was only weakly expressed
(Figure 2(C)). Taken together, these results show differ-
ent biochemical properties for lEV and sEV subpopula-
tions associated with differential expression of classical
EV markers and distinct sucrose flotation properties.
Adipocyte-derived lEVs and sEVs exhibit a specific
protein signature
To further characterise the protein composition of
adipocyte EV subpopulations, we performed label-free
quantitative proteomic analysis from four biological
replicates of total EVs, lEV and sEV populations
using MS. We identified 533 proteins, corresponding
to 408 groups of proteins (0.268% FDR peptides) from
all EV subgroups (Dataset S1).
This qualitative analysis allowed the identification of
217, 480 and 168 proteins in total EV, lEV and sEV
fractions, respectively (Dataset S2). A more conserva-
tive filtering was applied to consider proteins present
in EV fractions based on the detection of at least two
distinct peptides in two different biological replicates
(see the Methods section). A list of the identified pro-
teins, categorised according to gene ontology (GO)
annotations in the UniProt KB database, is presented
in Dataset S3. This included EV protein markers such
as tetraspanin CD81, the associated ESCRT-complex
protein Alix and the glycoprotein Mfge8. Defence and
immunity proteins, including class I major histocom-
patibility complex molecules and immunoglobulins,
were also detected, as expected [38]. In addition, multi-
ple proteins known to be involved in membrane traf-
ficking, such as Rab proteins, annexins, small
guanosine triphosphate (GTP)-binding proteins and
several cytoskeletal-related proteins (e.g. actin, tubulin,
α-actinin and myosin), were identified. Numerous pro-
teins with enzymatic activities or enzyme modulators,
mainly derived from mitochondria, were also present,
thus illustrating the trapping of the cytosolic part dur-
ing EV biogenesis. Furthermore, nucleic acid binding
proteins such as histones and ribosomal proteins were
found in the different EV subclasses. The presence of
extracellular matrix (ECM) proteins additionally illus-
trates the membranous origin of EVs. The identifica-
tion of signalling molecules such as complement
factors, lipoprotein lipase and the adipocyte-secreted
hormone adiponectin indicated the potential role of
adipocyte-derived EVs in systemic haemostasis and/or
glucidolipidic metabolism. Finally, the presence of
many transporters, transfer and carrier proteins, recep-
tors and signalling proteins highlights the ability of
such EVs to bind and/or transfer information to reci-
pient cells, therefore modulating their metabolism and/
or phenotype.
Comparison of the protein composition between the
different EV fractions showed that sEVs quasi-overlap
total EV protein content (Figure 3(A)). Conversely, the
lEV fraction, which represented the most enriched
fraction in terms of protein diversity, had 31.5% and
24.6% of proteins in common with total EVs and sEVs,
respectively (Figure 3(A)). Furthermore, principal
component analysis (PCA) of these qualitative compar-
isons highlighted the distinct protein composition of
the lEV fraction, compared to sEVs and total EVs
(Figure 3(B)). The co-segregation of total EVs and
sEVs (Figure 3(B)) is probably due to the higher pro-
portion of sEVs secreted by adipocytes, in comparison
to adipocyte-secreted lEVs (see Figure 1(B)). To
explore whether these different protein compositions
may reflect different functional properties of EV sub-
classes, we performed a GO term enrichment classifi-
cation of proteins for lEV and sEV fractions. Based on
a GO cellular component analysis, we highlighted a
specific enrichment of lEVs in membrane, organelles
and cell part components in comparison with sEVs, in
agreement with membrane-derived shedding of micro-
vesicles (Figure 3(C)). In contrast, the sEV fraction was
specifically enriched in ECM and macromolecular
complex components (Figure 3(C)). Subsequent
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Figure 3. Proteome characterisation by nano-liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis reveals the specific
protein signature of extracellular vesicle (EV) subpopulations. (A) Venn diagram of the identified proteins in total EV, large extracellular vesicle
(lEV) and small extracellular vesicle (sEV) populations. Proteinswere considered identifiedwhen at least two peptideswere detected in at least
two of the four biological replicates. The important overlap between total EV and sEV proteomes underlines the ability of 3T3-L1 adipocytes to
secrete abundant sEVs, in comparison to lEVs, in serum-deprived culture conditions. (B) Principal component analysis (PCA) of EV
subpopulations underlines the distinct protein composition between sEV and lEV fractions. Results are shown for the four independent
adipocyte-derived EV biological preparations (total EVs, lEVs and sEVs) analysed by nano-LC-MS/MS analysis. PCA of identified proteins for
each EV subtype shows a clear separation of lEVs from sEVs and total EVs. (C–E) Gene ontology (GO) terms of protein families enriched in lEV
and sEV preparations. Identified proteins in lEV and sEV fractions, respectively, were classified according to cellular component (C), biological
process (D) and molecular function (E) categories defined by the GO consortium using the Panther classification system database. (C) Cellular
component GO analysis reveals an enrichment of membrane and organelle components for lEVs, and in the extracellular region and
extracellular matrix for sEV. (D,E) GO categories with greater than five-fold enrichment are presented for lEV and sEV populations following
classification according to biological process (D) or molecular function (E). The [–log(P)] is shown for each category indicated, where P is the
significance. The dotted line represents the threshold (P = 0.01) over which the represented categories display a significant five-fold greater
enrichment than expected by chance.
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analyses based on biological process GO enrichment
identified the presence of proteins involved in many
metabolic pathways for both lEVs and sEVs, most of
them linked to mitochondrial function (Figure 3(D)).
GO analysis for molecular function confirmed the pre-
sence of many mitochondrial enzymes in the lEV frac-
tion, with a particular enrichment in oxydoreductases
(Figure 3(E)). In addition, proteins falling in the cate-
gories “protein folding, complex assembly and biogen-
esis” (Figure 3(D)), as well as components such as
enzymes and factors critical for translation pathways
(Figure 3(E)), were overrepresented in both EV sub-
populations. The sEV fraction revealed a specific
enrichment in processes related to cell adhesion as
well as in macrophage activation (Figure 3(D)).
Altogether, proteomic analysis of adipocyte-secreted
EV subpopulations demonstrates specific protein com-
position, which could predict different systemic meta-
bolic responses.
Identification and validation of specific protein
markers of adipocyte-derived lEVs and sEVs
To identify and validate specific EV markers of lEV-
and sEV-derived adipocytes, we performed a quantita-
tive analysis of our proteomic data based on SC and
XIC analysis of selected peptide ions (see Methods),
two methods of analysis that have been shown to
correlate well with protein abundances in complex
biological samples [39,40]. Based on SC and XIC sta-
tistical analysis of the results (p < 0.05), we were able to
identify proteins that display significant enrichment in
the lEV (Table 1) and sEV (Table 2) fractions.
Proteins that were specifically enriched in the lEV
fractions were more abundant than in sEVs; this is likely
to be related to the higher diversity of proteins recovered
in the lEV fractions (Dataset S2). Among the classical
class of protein families associated with EVs, we high-
lighted a specific enrichment of the lEV subpopulation in
numerous metabolic enzymes, nucleic acid binding pro-
teins (especially 40S and 60S ribosomal proteins), chaper-
ones, including some heat shock proteins (HSP7 C,
HSP90β, GRP78 and GRP75), cytoskeleton-related pro-
teins (including actins and β-tubulin chains), membrane
traffic proteins such as annexins and Rab GTPases, trans-
porters (ADP/ATP translocase, mitochondrial channels,
ATP synthase subunits and the fatty acid binding protein
transporter FABP4/aP2) (Table 1). By contrast, sEV frac-
tions were specifically enriched in ECM proteins,
T-complex protein 1 chaperones, histones and MVP, as
well as some metabolic enzymes involved in lipid and
carbohydrate synthesis (Table 2). To validate the
statistical analysis of our quantitative proteomic data
and to confirm the respective enrichment of proteins in
the lEV and sEV subpopulations, we analysed the expres-
sion of a selection of proteins, highly expressed in adipo-
cytes, by Western blot from equal loading of lEVs and
sEVs on SDS-PAGE gels (Figure 4). This confirmed the
specific enrichment of FABP4/aP2, 14-3-3, annexin A2
and endoplasmin in lEV preparations (Figure 4(A)),
whereas MVP, FAS and adiponectin were specifically
targeted to the sEV fraction (Figure 4(B)). We also inves-
tigated the enrichment of actinin-4 and syntenin-1, two
proteins found in our proteomic analysis and recently
described as potential novel markers of lEVs and sEVs,
respectively [41,42]. Whereas we confirmed the specific
association of actinin-4 with lEVs, syntenin-1 expression
was equally detected in lEV and sEV preparations
(Figure 4(C)).
Altogether, our analysis of adipocyte-derived EV
proteomics data allowed us to identify EV markers
for the lEV and sEV subpopulations, which could be
further used to differentiate these two EV subtypes.
Moreover, these markers formally identify EVs as
potential cargos for the sorting and secretion of key
adipocyte signalling proteins, such as adiponectin and
FABP4/aP2, which are known to play critical roles in
glucidolipidic metabolism at the level of the organism.
Adipocyte-derived lEVs and sEVs present specific
lipid characteristics
Besides protein-specific targeting to EVs, which may
affect the signalling responses in recipient cells, lipids
may also play critical roles in EV functions. To analyse
in depth the lipid content of EV subpopulations, we
performed a quantitative analysis of neutral lipids and
phospholipids (PLs) by MS of lEV and sEV fractions,
based on three independent biological samples for each
subclass. Lipid concentrations (measured as µg lipids/µg
protein) in lEVs and sEVs showed that PLs and SPs
constituted the main lipid classes retrieved from these
EV preparations, whereas only traces of glycerolipids
(GLs) were detected (Figure 5(A)). The molecular lipid
species measured belonged to nine lipid classes, with five
different types of PL (LPC, PC, PE, PI and PS); SPs,
including ceramides (Cer), glycosylceramides (GlyCer)
and sphingomyelin (SM); and diacylglycerols (DGs)
representing the GLs (Figure 5(B)). PC represents by far
the main PL (nearly 60% of total PL) present in lEVs and
sEVs, whereas LPC, PS, PI and PE are proportionally
minor PLs. SM is also particularly enriched in EV frac-
tions and constitutes the main SP (23–24%) in adipocyte-
derived EVs. Only small amounts of Cer (< 1%) and
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Table 1. Proteins specifically enriched in large extracellular vesicle (lEV) preparations.
XIC SC
Protein
class Acc. no.
Entry
name Protein description
lEV/
sEV
ratio
Quantification
(p value)
Median of SC
values
(lEV/sEV)
Quantification
(p value)
Chaperones
P08113 ENPL Endoplasmin 2.2 2.0E-02 7/0.5 1.9E-02
P11499 HS90B Heat shock protein HSP 90-beta 1.7 3.6E-02 12/3 2.0E-02
P20029 GRP78 78 kDa glucose-regulated protein 3.7 2.4E-04 13.5/1 1.8E-02
P38647 GRP75 Stress-70 protein, mitochondrial 3.0 2.8E-02 9/0 1.4E-02
P63017 HSP7 C Heat shock cognate 71 kDa protein NA 7.4E-01 10/2 2.0E-02
P63038 CH60 60 kDa heat shock protein, mitochondrial 3.7 4.1E-02 10/0 1.4E-02
P63101 1433Z 14-3-3 protein zeta/delta 9.2 3.0E-06 4/0 NA
Q9CQV8 1433B 14-3-3 protein beta/alpha 1.7 5.0E-02 4,5/0 NA
Cytoskeleton-related proteins
P13020 GELS Gelsolin 4.1 3.9E-03 9.5/0 1.8E-02
P26041 MOES Moesin 6.3 2.5E-03 3.5/0 NA
P60710 ACTB Actin, cytoplasmic 1 NA NA 16/6 2.0E-02
P63260 ACTG Actin, cytoplasmic 2 NA NA 15.5/6 2.0E-02
P68368 TBA4A Tubulin alpha-4A chain 1.9 1.6E-02 9.5/4.5 NA
P68372 TBB4B Tubulin beta-4B chain NA 9.8E-01 10/2 2.8E-02
P99024 TBB5 Tubulin beta-5 chain NA 2.4E-01 10.5/3 2.0E-02
Q61879 MYH10 Myosin-10 1.5 1.4E-02 5.5/0 1.2E-01
Q8VDD5 MYH9 Myosin-9 NA 5.7E-02 7.5/2.5 2.1E-02
Q9WTI7 MYO1 C Unconventional myosin-Ic 2.1 7.2E-03 11/0 1.7E-02
Enzyme modulators
P08752 GNAI2 Guanine nucleotide-binding protein G 12.2 1.6E-05 3.5/0 NA
P62880 GBB2 Guanine nucleotide-binding protein G 3.3 6.5E-04 4.5/0 NA
Membrane traffic proteins
P07356 ANXA2 Annexin A2 3.0 7.1E-05 18/2 1.7E-02
P10107 ANXA1 Annexin A1 6.9 5.4E-06 9.5/0 1.4E-02
P14824 ANXA6 Annexin A6 2.1 5.1E-04 15/2.5 1.9E-02
P48036 ANXA5 Annexin A5 3.9 3.6E-04 7.5/0 1.9E-02
P51150 RAB7A Ras-related protein Rab-7a 2.8 9.6E-03 4/0 NA
P97429 ANXA4 Annexin A4 4.9 5.4E-04 7.5/0 1.7E-02
Nucleic acid binding proteins
P10126 EF1A1 Elongation factor 1-alpha 1 4.3 1.2E-04 6.5/1.5 2.1E-02
P25444 RS2 40S ribosomal protein S2 4.8 2.1E-03 2.5/0 NA
P27659 RL3 60S ribosomal protein L3 4.2 1.9E-04 3.5/0 NA
P47911 RL6 60S ribosomal protein L6 2.4 2.9E-02 4/0 NA
P62242 RS8 40S ribosomal protein S8 2.5 4.4E-02 4.5/1.5 NA
P62754 RS6 40S ribosomal protein S6 3.2 5.4E-03 5/0 NA
P97351 RS3A 40S ribosomal protein S3a 2.4 2.2E-03 4/0 NA
Protein with enzymatic activities
O88844 IDHC Isocitrate dehydrogenase [NADP] cytoplasmic 2.7 3.4E-04 4/0 NA
P05064 ALDOA Fructose-bisphosphate aldolase A 9.1 8.9E-06 6/0 1.7E-02
P06151 LDHA L-lactate dehydrogenase A chain 3.0 1.3E-02 3.5/0 NA
P08249 MDHM Malate dehydrogenase, mitochondrial NA 1.4E-01 9.5/0 1.4E-02
P10852 4F2 4F2 cell-surface antigen heavy chain 22.0 1.4E-04 6.5/0 NA
P14152 MDHC Malate dehydrogenase, cytoplasmic 5.0 8.4E-04 3.5/0 NA
P17182 ENOA Alpha-enolase 2.2 2.2E-03 7.5/1.5 2.1E-02
P17751 TPIS Triosephosphate isomerase 3.5 1.7E-04 4.5/1 NA
P24270 CATA Catalase 4.7 2.4E-04 6.5/0 1.3E-02
P35700 PRDX1 Peroxiredoxin-1 7.0 4.6E-04 4/0 NA
P41216 ACSL1 Long-chain fatty-acid–CoA ligase 1 NA 5.4E-01 24/8 2.0E-02
P51660 DHB4 Peroxisomal multifunctional enzyme type 2 2.9 9.7E-03 4.5/0 1.4E-02
Q00519 XDH Xanthine dehydrogenase/oxidase 8.9 2.0E-02 2/0 NA
Q8BMS1 ECHA Trifunctional enzyme subunit alpha, mitochondrial NA 2.4E-01 9/0 1.4E-02
Q9EQ20 MMSA Methylmalonate-semialdehyde dehydrogenase [acylating],
mitochondrial
2.8 2.6E-02 4.5/0.5 NA
Q921H8 THIKA 3-Ketoacyl-CoA thiolase A, peroxisomal 1.3 3.8E-02 1/0 NA
Q99LC5 ETFA Electron transfer flavoprotein subunit alpha,
mitochondrial
3.5 1.6E-03 4.5/0 NA
Transporter, transfer and carrier proteins
P04117 FABP4 Fatty acid-binding protein, adipocyte 3.3 2.6E-03 9/0.5 1.9E-02
P48962 ADT1 ADP/ATP translocase 1 NA 2.0E-01 5/0 1.3E-02
P51881 ADT2 ADP/ATP translocase 2 6.5 1.5E-02 5.5/0 1.4E-02
P56480 ATPB ATP synthase subunit beta, mitochondrial NA 5.4E-01 13/4 2.0E-02
Q03265 ATPA ATP synthase subunit alpha, mitochondrial 6.3 5.2E-03 9/1 1.7E-02
Q8VDN2 AT1A1 Sodium/potassium-transporting ATPase subunit alpha-1 7.3 7.7E-04 5/0 NA
(Continued )
12 M. DURCIN ET AL.
D
ow
nl
oa
de
d 
by
 [1
93
.52
.40
.1]
 at
 08
:54
 02
 N
ov
em
be
r 2
01
7 
GlyCer (< 1%) were measured. Finally, DGs, at 1%,
illustrated the trace amount of GLs. Absolute molar con-
centrations of these different lipid classes were unchanged
between total EVs, lEVs and sEVs, confirming a similar
PL and neutral lipid profile for these different EV sub-
populations (Figure S2). Closer examination of the mole-
cular profile of the fatty acid composition of EV-
associated lipids did not reveal significant changes, either
in acyl chains lengths or in the degree of fatty acid
saturation for PLs (Figure S3), SPs and GLs (Figure S4).
This lipidomic analysis was completed by total choles-
terol measurement based on a colorimetric assay.
Whereas PL are by far the main constituent of cell mem-
branes, membrane cholesterol content is a key determi-
nant of membrane structure and dynamics.Wemeasured
significantly higher cholesterol content in sEVs than in
lEVs (relative to total EV protein content) (Figure 5(C)),
therefore identifying this high sterol content as a char-
acteristic trait of adipocyte sEV populations.
Since microvesicle shedding is known to happen
following the loss of membrane asymmetry, leading
to the subsequent exposure of PS [17], we also sought
to investigate PS exposure in EV subpopulations, by
measuring their annexin V positivity by flow cytome-
try. Despite the absence of quantitative changes in PS
content between lEVs and sEVs (see Figure S2), we
highlighted that 60% of PS associated with the lEV
fractions was externalised, whereas the sEV fractions
showed very low annexin V positivity (Figure 5(D)).
Thus, sEV and lEV populations could be distinguished
on the basis of their cholesterol content and externa-
lised PS.
These results therefore identify new lipid markers
that may affect the biological responses to EVs in
recipient cells.
Secretion of lEVs and sEVs from adipocytes is
induced by stimuli related to the chronic low-grade
inflammation state of obesity
We next investigated whether the secretion of adipocyte-
derived EVs may be enhanced by external stimuli in the
context of the chronic low-grade inflammation state asso-
ciated with obesity. For this purpose, we selected stimuli
that are known to be relevant in the context of adipose
tissue hypertrophia [43–45] and have also been identified
as enhancing EV secretion. Therefore, lEV and sEV sub-
populations were collected after 24 h exposure to calcium
ionophore ionomycin [46,47], PA, OA [12,22], 8-Br-
cAMP mimicking prolonged lipolytic stimulation [14],
angiotensin-II [48] and inflammatory cytokines such as
TNFα and INFγ [49,50]. These experiments were con-
ducted in serum-free conditions and EV release was quan-
tified by NTA (Figure 6(A)). First, we confirmed that
ionomycin induced lEV secretion, in agreement with the
well-established role of increased intracellular calcium in
the shedding of plasma membrane-derived vesicles [46].
Moreover, we revealed the specific potency of PA, unlike
OA, to significantly enhance secretion of both lEVs and
sEVs (Figure 6(A,B)). Finally, our results also highlighted
the induction of both lEV and sEV production following
exposure to TNFα, whereas EV secretion was maintained
at basal levels following INFγ treatment (Figure 6B). No
induction of EV secretion was observed following angio-
tensin II treatment.
Taken together, these data demonstrate the ability of
specific stimuli, which have been described to take part
in the metabolic complications associated with obesity,
to stimulate lEV and/or sEV populations. Therefore,
adipocyte-derived lEVs and sEVs may be viewed as
messengers or relayers of metabolic responses asso-
ciated with the pathophysiological context of obesity.
Table 1. (Continued).
XIC SC
Protein
class Acc. no.
Entry
name Protein description
lEV/
sEV
ratio
Quantification
(p value)
Median of SC
values
(lEV/sEV)
Quantification
(p value)
Miscellaneous
O35129 PHB2 Prohibitin-2 NA 5.2E-02 7/0 1.4E-02
P09103 PDIA1 Protein disulphide-isomerase 5.6 7.0E-05 4.5/0 NA
P27773 PDIA3 Protein disulphide-isomerase A3 3.1 8.8E-05 9/0 1.1E-02
P67778 PHB Prohibitin 7.3 7.4E-03 6/0 4.7E-02
Q922R8 PDIA6 Protein disulphide-isomerase A6 1.9 4.2E-02 3/0 NA
Protein enrichment in large extracellular vesicle (lEV) and small extracellular vesicle (sEV) subpopulations was compared, and significant statistical
enrichment of proteins in lEVs, based on spectral counting (SC) and extracted ion chromatography (XIC) analysis, is presented. Enrichment was considered
on the basis of a difference of at least five spectra between at least two biological samples. The p values and ratio calculated following SC and XIC analysis
are presented. The XIC ratio was calculated with the median of area peptides (for one protein) from the four independent replicates of lEVs divided by the
median of all peptides (for the same protein) from the four independent replicates of sEVs. The SC ratio corresponds to the median of SC detected for one
protein in the four independent replicates of lEVs to the median of SC detected for the same protein in the four independent replicates of sEVs. Proteins
were considered enriched in lEVs when p < 0.05 following XIC and/or SC analysis. Proteins exclusively found in lEV samples are shown in bold. Those p
values not found to be statistically different are in grey. Acc. no., accession number; NA, not available.
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Murine primary adipocytes secrete lEVs and sEVs
with similar morphological and biochemical
characteristics to EVs secreted by 3T3-L1
adipocytes
We next investigated whether such EV secretion also hap-
pens in vivo. We therefore studied EV release by isolating
adipocytes frommurine visceral fat pads, cultured for 24 h
in serum-free conditions. EV isolation of cell-cleared con-
ditioned media revealed the ability of primary adipocytes
to secrete both lEVs and sEVs in similar proportions, based
on EV protein content secreted per gram of dissected
adipose tissue (Figure 7(A)). Electron microscopy imaging
(Figure 7(B)) and NTA (Figure 7(D)) confirmed the pre-
sence of lEVs and sEVs in the pelleted material at
13,000 × g and 100,000 × g, respectively. Isolated EV
subpopulations from primary adipocytes presented similar
morphological traits and sizes (Figure 7(E)) to 3T3-L1
adipocyte-derived EVs (Figure 1). NTA corroborates the
equal secretion of lEVs and sEVs by isolated adipocytes,
corresponding to 82.4 ± 12.8 lEVs and 101.8 ± 66.9 sEVs
secreted per isolated adipocyte, in contrast to 3T3-L1,
which secreted mainly sEVs. Finally, biochemical analysis
of these EV subpopulations confirms the specific
Table 2. Proteins specifically enriched in small extracellular vesicle (sEV) preparations.
XIC SC
Protein
class Acc. no.
Entry
name Protein description
sEV/lEV
ratio
Quantification
(p value)
Median of SC values
(sEV/lEV)
Quantification
(p value)
Chaperones
P80314 TCPB T-complex protein 1 subunit beta 2.9 1.6E-02 3.5/2 NA
P80317 TCPZ T-complex protein 1 subunit zeta 6.6 1.1E-02 0.5/2 NA
Enzyme modulators
P68040 GBLP Guanine nucleotide-binding protein subunit
beta-2-like 1
2.5 8.9E-03 3.5/6.5 NA
Extracellular matrix proteins
P02468 LAMC1 Laminin subunit gamma-1 7.9 1.1E-03 4.5/1 NA
P10493 NID1 Nidogen-1 7.7 1.9E-03 9.5/2 5.8E-02
P11087 CO1A1 Collagen alpha-1 16.5 1.7E-04 4.5/0 NA
P11276 FINC Fibronectin 36.8 3.4E-04 32.5/0 1.8E-02
P37889 FBLN2 Fibulin-2 12.8 6.1E-06 24/2.5 2.1E-02
P97927 LAMA4 Laminin subunit alpha-4 3.6 3.0E-03 6.5/2 NA
Q02788 CO6A2 Collagen alpha-2 82.4 4.1E-06 32.5/0 1.8E-02
Q04857 CO6A1 Collagen alpha-1 114.3 3.3E-06 42.5/4 2.1E-02
Q07797 LG3BP Galectin-3-binding protein 127.3 5.1E-06 23/0 1.8E-02
Q8CG85 MAMC2 MAM domain-containing protein 2 20.0 3.1E-04 5/0 1.4E-02
Q99K41 EMIL1 EMILIN-1 14.1 8.0E-05 13.5/0 1.7E-02
Q9WVJ9 FBLN4 EGF-containing fibulin-like extracellular
matrix protein 2
6.5 3.8E-03 6/0 1.4E-02
Membrane traffic proteins
Q9JHU4 DYHC1 Cytoplasmic dynein 1 heavy chain 1 2.3 1.1E-03 3.5/4.5 NA
Q68FD5 CLH1 Clathrin heavy chain 1 4.2 6.5E-04 24.5/17 3.9E-01
Nucleic acid binding proteins
P10853 H2B1F Histone H2B type 1-F/J/L 5.6 3.0E-02 6.5/3.5 NA
P62806 H4 Histone H4 4.5 2.5E-02 13.5/9.5 NA
P14206 RSSA 40S ribosomal protein SA 1.8 3.6E-02 3.5/3.5 NA
Q9EQK5 MVP Major vault protein 35.1 4.1E-08 30.5/2.5 1.9E-02
Proteins with enzymatic activities
P12382 PFKAL ATP-dependent 6-phosphofructokinase, liver
type
2.2 1.7E-02 0.5/2.5 NA
P19096 FAS Fatty acid synthase 3.3 3.2E-03 28/20 6.6E-01
P28271 ACOC Cytoplasmic aconitate hydratase 2.7 3.5E-04 3.0/3.0 NA
P54310 LIPS Hormone-sensitive lipase 2.5 3.5E-04 3.0/4 NA
P97873 LOXL1 Lysyl oxidase homologue 1 5.2 3.3E-02 6.5/3.5 NA
Q00612 G6PD1 Glucose-6-phosphate 1-dehydrogenase X 8.8 1.5E-02 0/2 NA
Q01853 TERA Transitional endoplasmic reticulum ATPase 3.1 7.8E-04 3.5/3.5 NA
Q5SWU9 ACACA Acetyl-CoA carboxylase 1 13.4 1.3E-04 15.0/1 2.8E-02
Signalling molecules
P11152 LIPL Lipoprotein lipase 4.2 1.6E-03 13.5/8.5 NA
Q60994 ADIPO Adiponectin 8.8 8.5E-04 4.5/1.5 NA
Miscellaneous
P08003 Pdia4 Protein disulphide-isomerase A4 14.5 4.5E-05 0/1.5 NA
Protein enrichment in large extracellular vesicle (lEV) and small extracellular vesicle (sEV) subpopulations was compared and significant statistical enrichment
of proteins in sEVs, based on spectral counting (SC) and extracted ion chromatography (XIC) analysis, is presented. Enrichment was considered on the basis
of a difference of at least five spectra between at least two biological samples. The p values and ratio calculated following SC and XIC analysis are
presented. The XIC ratio was calculated with the median of area peptides (for one protein) from the four independent replicates of sEVs divided by the
median of area peptides (for the same protein) from the four independent replicates of lEVs. The SC ratio corresponds to the median of SC detected for
one protein in the four independent replicates of sEVs to the median of SC detected for the same protein in the four independent replicates of lEVs.
Proteins were considered enriched in sEVs when p < 0.05 following XIC and/or SC analysis. Proteins exclusively found in sEV samples are shown in bold.
Those p values not found to be statistically different are in grey. Acc. no., accession number; NA, not available.
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association of the tetraspanins CD9 and CD63 with sEVs,
whereas the membranous proteins flotillin-2 and caveolin-
1 were preferentially retrieved in lEVs.
These results highlight the ability of in vivo adipocytes
to secrete non-negligible amounts of EVs, which can be
separated into small and large subpopulations. The lEVs
Figure 4. Validation of proteomics data and identification of specific markers of large extracellular vesicles (lEVs) and small
extracellular vesicle (sEVs). (A,B) Western blot analysis of selected proteins identified by the quantitative analysis of proteomic
data. Equal amounts of protein (8 µg) for lEVs or sEVs were loaded on a sodium dodecyl sulphate–polyacrylamide gel electrophor-
esis gel and immunoblotted for selected proteins found to be enriched in either lEV or sEV preparations, based on the statistical
analysis of quantitative proteomic data. For each selected protein, a representative immunoblot is presented. Quantifications of
signal intensity are represented as dot plots and calculated from three to seven independent experiments as described in Figure 2
(B). The colours used represent different biological replicates used for the immunoblots. These results were confirmed by
immunoblotting the specific enrichment of ap2/FABP4, 14-3-3, annexin A2 and endoplasmin in lEV fractions, whereas adiponectin,
major vault protein (MVP) and FAS are specifically enriched in sEV fractions. (C,D) Western blot of actinin-4 (C) and syntenin-1 (D) in
lEV and sEV subpopulations. Actinin-4 is found to preferentially associate with lEVs, whereas syntenin-1 expression is equally
distributed in lEV and sEV preparations.
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and sEVs had physical and biological characteristics
similar to those described for 3T3-L1, predicting differ-
ential functional effects on target cells and/or tissues.
Discussion
Emerging roles of EVs in the pathophysiology of many
diseases have revealed technical pitfalls and potential
Figure 5. Lipidomic characterisation of large extracellular vesicles (lEVs) and small extracellular vesicles (sEVs) by liquid chromato-
graphy–tandem mass spectrometry (LC-MS/MS). (A) The total amount of lEV and sEV membrane lipids as determined by LC-MS/MS
is expressed in micrograms normalised to the amount of extracellular vesicle (EV) protein content. The term phospholipids
represents the sum of phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI) and phosphatidylserine
(PS). Sphingolipids include ceramides (Cer), glycosylceramides (GlyCer) and sphingomyelin (SM). Glycerolipids are uniquely
represented by diacylglycerols (DGs). Data presented for each lipid concentration represent the mean of four individual lEV and
sEV preparations each. (B) Composition of lEV and sEV membrane lipids according to lipid classes. Data are expressed as a
percentage of the total lipid content determined for each statistical group and represent the mean of four individual lEV and sEV
preparations each. See (A) for definitions of each lipid species. (C) sEV preparations are specifically enriched in cholesterol. The
cholesterol content was measured in isopropanol-resuspended EV membrane lipids using a colorimetric assay. The total amount of
cholesterol measured is expressed in micrograms normalised to the amount of EV protein content. n = 5–8 biological samples for
lEVs and for sEVs, *p < 0.05 (Mann–Whitney rank test). (D) Measurement of annexin V positivity of adipocyte-derived lEVs and sEVs
by flow cytometry. High annexin V binding of adipocyte-derived lEVs illustrates a higher proportion of externalised PS in lEVs than
in sEV preparations. n = 3 independent lEV and sEV preparations, *p < 0.05 (paired Student’s t test)
16 M. DURCIN ET AL.
D
ow
nl
oa
de
d 
by
 [1
93
.52
.40
.1]
 at
 08
:54
 02
 N
ov
em
be
r 2
01
7 
artefacts, which need to be addressed to fully clarify the
properties of EVs and their biological significance [20]. In
addition, the heterogeneity between EV subclasses pin-
points the need to identify and define EV subtypes before
characterising their functional properties [41,42].
The present study aimed to present a comprehensive
overview of EV subtypes secreted by 3T3-L1 mature adi-
pocytes by separating lEV populations (probably including
microvesicles) from sEV subsets (including exosomes).We
provide evidence that lEVs and sEVs present distinct bio-
logical and biochemical properties based on: (i) distinct
morphological and size parameters; (ii) different sucrose
flotation properties; (iii) distinct protein patterns;
(iv) subtle changes in their lipid content and distribution;
and (v) specific responses to biological stimuli.
Our data confirm that adipocytes secrete significant
amounts of EVs, including lEVs and sEVs. By comparison
to the secretion of exosomes measured previously [11,21],
we obtained a similar amount of sEVs, highlighting adi-
pocytes as a provider of sEVs, which could be assimilated
to exosomes as previously described in adipocytes. Indeed,
the secretion of adipocyte-derived exosomes has been
Figure 6. Large extracellular vesicle (lEV) and small extracellular vesicle (sEV) secretion following exposure to external stimuli. (A,B)
Nanoparticle tracking analysis quantification of lEV (A) and sEV (B) secretion following 24 h treatment of 3T3-L1 matures adipocytes
in serum-deprived conditions with the following stimuli: bovine serum albumin-conjugated oleic or palmitic acid (OA or PA, 500 µM
each), 8-bromoadenosine 3’,5’-cyclic monophosphate (8-Br-cAMP) (1 µM), ionomycin (Iono, 1.5 µM), angiotensin II (AngII, 10 nM),
interferon-γ (INFγ, 100 U/mL corresponding to 5 ng/mL and tumour necrosis factor-α (TNFα, 10ng/mL. Extracellular vesicles secreted
per adipocyte are represented as dot plots and calculated from three to five independent experiments. *p < 0.05, **p < 0.01 (Mann–
Whitney rank test).
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estimated to be 10-fold higher than exosome secretion
from cancerous melanoma cell lines [21]. Compared with
this important sEV secretion by 3T3-L1 mature cells, lEV
secretion appears to be negligible (around 100-fold lower
than sEV secretion). Serum-deprived conditions, which
are used to avoid contamination with serum-derived
exosomes, may, however, favour the secretion of basal
exosomes and therefore contribute to the high proportion
of secreted sEVs. Indeed, lEVs and sEVs were secreted in
equivalent amounts from adipocytes isolated from visceral
adipose tissue, reinforcing the need to distinguish between
and study the different EV subpopulations. Despite the
Figure 7. Primary adipocytes secrete large extracellular vesicles (lEVs) and small extracellular vesicles (sEVs), compared to 3T3-L1
adipocytes. (A) Primary adipocyte-derived extracellular vesicle (EV) production based on protein content of EV subtypes. The protein
content of each EV pellet per gram of dissected adipose tissue is presented. Similar production of lEVs and sEVs was measured.
n = 3 independent EV preparations. (B) Transmission electron microscopy images of lEV and sEV pellets. Scale bars = 200 nm. (C–F)
Nanoparticle tracking analysis of lEV and sEV populations. Determination of size distribution and concentration of lEV (C) and sEV
(D) preparations. Indicated concentrations refer to the concentration of EVs secreted per gram of dissected adipose tissue and are
expressed as 105 particles/g adipose tissue. Each coloured line represents the mean of five videos acquired for a single biological
sample. EV mean size (E) and EVs released per cell (H) are presented. The number of isolated adipocytes from dissected fat pads was
indirectly estimated, as described in the Methods section. The same colours are used in C–F to distinguish the three different lEV/
sEV preparations analysed. lEV pellets contained larger vesicles than sEV pellets. Primary adipocytes secrete equal amounts of sEVs
and lEVs when cultured in serum-deprived conditions. n = 3 biological samples for lEVs and for sEVs, *p < 0.05 (Mann–Whitney rank
test). (G) Western blot analysis of different EV markers in EV subpopulations isolated from primary adipocytes: 8 µg of either lEVs or
sEVs was loaded on a sodium dodecyl sulphate–polyacrylamide gel electrophoresis gel, together with 8 µg of original adipocyte cell
lysate (CL), and analysed by immunoblotting for the presence of the following proteins: CD9, CD63, Mfge8, flotillin-2 and caveolin-1.
A black line was inserted on the immunoblots when samples were loaded on the same gel, but not side by side. One representative
blot for each protein is presented.
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lower secretion of lEVs compared to sEVs in 3T3-L1
adipocytes, a larger diversity of proteins was identified in
the lEV fractions, dissociating the amount of EVs secreted
per cell and their quality (referring to their protein signa-
ture). The manymore unique proteins in lEVs may simply
be related to the highest ability of large vesicles to encom-
pass more material, especially cytosolic proteins, as illu-
strated by the numerous enzymes recovered in the lEV
fractions. Another plausible explanation may rely on the
specific sorting of exosomes from MVBs, which is known
to be controlled by Rab GTPases and other ESCRT pro-
teins [51,52], therefore leading to the engulfment of a
restricted number of proteins in sEVs. Nonetheless, we
cannot rule out that such specific sorting processes also
exist for microvesicles, since the Rho family of small
GTPases has also been involved in microvesicle shedding
in response to different stimuli [53–55].
Identification of selective markers of EV subsets
constitutes a critical issue to distinguish between the
shared and specific functional properties of lEVs and
sEVs. We first confirmed by Western blot a specific
enrichment of sEVs in the exosomal markers Alix,
TSG101 and tetraspanins (CD9, CD63 and CD81).
However, tetraspanins (with the exception of CD81)
were not detected in the quantitative proteomic analy-
sis of EVs, probably because of their membrane-
anchored nature. Nevertheless, proteomic profiling
between lEVs and sEVs enabled us to identify new
potential protein markers for large and small vesicles,
confirmed by Western blotting, based on their selective
presence or enrichment in one of these two EV sub-
types. We identified β-actin specifically in lEVs and
confirmed the enrichment of lEVs with endoplasmin
(also called gp96) and actinin-4, as recently reported
[41,42]. By contrast, we identified MVP to be specifi-
cally enriched in sEVs, whereas it has recently been
shown to preferentially associate with lEV subsets [41].
Similarly, syntenin-1, shown to be highly specific to the
light sEVs in the same study [41], was, in our experi-
mental conditions, equally distributed between lEVs
and sEVs. These discrepancies could be explained by:
(i) the EV-producing cell model (adipocytes vs dendri-
tic cells), which may express differently the proteins
concerned; and/or (ii) the isolation procedure for lEVs,
which differ since we pelleted lEVs at 15,000 × g
(whereas others used 10,000 × g centrifugation, leading
to the co-isolation of part of our lEVs in their exosomal
preparations). Such results underline the necessity of
using a combination of different protein markers to
face and overcome the differences between cell models.
One approach to categorising EV subsets may be to
combine different analyses including their lipid
contents. From this perspective, we performed a quan-
titative lipidomic analysis of lEVs and sEVs to assess
the specific lipid characteristics of these two EV cate-
gories. Similar PL profiles were obtained for lEVs and
sEVs, which confirms the high enrichment of EVs in
SM and PC lipid classes [11,56]. Despite no quantita-
tive changes in the different lipid classes between the
two EV subsets, we highlighted a high proportion of
externalised PS in lEVs and a specific enrichment of
cholesterol in sEV preparations. These subtle changes
were not evidenced in the lipidomic analysis performed
by MS, but only detected following additional analysis
of EV samples by flow cytometry, for testing annexin V
positivity, and by the quantification of cholesterol con-
tent following colorimetric assay. A high proportion of
sterols, relative to total PLs, has already been shown to
be a specific trait of exosomes [56], which may be
related to a particular enrichment of lipid-raft-like
domains in this EV population [57]. In addition,
annexin V positivity is a biological parameter often
associated with the characterisation of lEVs, particu-
larly in the cardiovascular field, since it predicts the
pro-coagulant potential of this EV subclass [58].
Altogether, our results argue for the use of these lipid
characteristics, in addition to morphometric and bio-
chemical parameters, since it can help to categorise EV
subtypes and may also influence intrinsic EV
properties.
So far, all of the studies investigating adipocyte-derived
EVs have focused on exosomes [8,9,11,21]. Notably, adi-
pose tissue-derived exosomes are increased in the context
of obesity both in animal models [8] and in humans [21].
Enhanced circulating levels of total microvesicles and exo-
somes have been detected in obese patients [2,3,5], suggest-
ing that adipocyte-derived EVs may contribute to such an
increase. We confirmed the association of two specific
adipose proteins (ap2/FABP4 and adiponectin) on EVs,
as previously described [12–14], and their respective
enrichment on either lEVs (for ap2/FABP4) or sEVs (for
adiponectin). Such results highlight their potential to be
used to characterise and evaluate the biodistribution of
adipocyte-derived EV subclasses from body fluids.
In agreement with a potential role of adipocyte-
derived EVs in metabolic complications associated with
obesity, we observed an increase in adipocyte-derived EV
secretion following stimulation with the calcium iono-
phore ionomycin, elevated PA and exposure to TNFα
These biological stimuli have all been associated with
increased fat mass, and constitute critical signals in the
myriad of cellular and subcellular dysfunctional networks
associated with metabolic diseases in the context of obe-
sity [43,59]. In particular, PA appears to be a potent
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inducer of both lEV and sEV secretion. Increased plasma
levels of free fatty acids, such as PA, occur in states of
obesity and are proposed to play an important role in the
development of insulin resistance, notably through the
formation of ceramides and their pro-inflammatory-
induced responses [60]. De novo synthesis of ceramides
from PA has also been shown to regulate the inward
budding of MVBs [61] and, accordingly, to enhance
sEV secretion from adipocytes [10,62] and from skeletal
muscle cells [22]. Nevertheless, the so-called “exosomes”
fraction may contain lEVs, depending on the isolation
procedure used. Previous work has shown that exosomes
are likely to transfer the deleterious effect of PA between
muscle cells, thereby participating in the alteration of
muscle homeostasis following lipid-induced insulin resis-
tance in mice [22]. In the light of our study, it would be
necessary to reconsider all EV populations as potential
carriers of lipids related to diet-induced changes in fatty
acid composition, which may play important roles in the
deleterious effects of lipid-induced insulin resistance at
the level of the whole organism.
EVs are now recognised as biological vectors of
cellular communication. Our quantitative proteomic
analysis of adipocyte-derived EVs revealed that lEV
and sEV subpopulations present specific signatures,
which may reflect different biological and functional
properties on recipient cells and tissues. Studies inves-
tigating the functional responses of adipocyte-derived
exosomes have revealed their ability to modulate
macrophage activation [8], insulin response [7] and
even tumorogenicity [21]. In the light of our study,
showing that lEVs carry many proteins from diverse
origins and are specifically enriched in metabolic
enzymes (mainly of mitochondrial origin), one can
advance the hypothesis that they may modulate meta-
bolic pathways in recipient cells, such as fatty acid
oxidation, a feature already attributed to adipocyte
exosomes [21]. Moreover, high annexin V binding of
adipocyte-derived lEVs could predict specific pro-coa-
gulant properties of this fat cell EV subtype, in agree-
ment with the detection of tissue factor proteins only in
the lEV fractions (see Dataset S2), and may participate
in the cardiovascular complications associated with
obesity. Therefore, our results highlight the need to
distinguish adipocyte-derived subtypes to delineate
their respective functional properties.
Altogether, this study provides additional information
and clues to characterise and define EV subtypes based
on the characterisation of adipocyte-derived EV popula-
tions. From a more general perspective, it illustrates the
need for a combination of multiple techniques to appreci-
ate the complexity of EV subtypes before investigating
their functional roles.
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